| Description | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß(1-40) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination of human free anti-insulin antibodies (AIA) in serum and plasma. FDA exempt, can be used for in-vitro diagnostics. | Radioimmunoassay (RIA) for the determination of glucagon in human plasma. FDA exempt, can be used for in-vitro diagnostics. | Solid phase direct sandwich ELISA for the determination of Lysozyme in human plasma, serum, or stool. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | Anti-Rituximab (Rituxan®) | Anti-Insulin Antibodies (AIA) | 0 / 3 - 30 Arbitrary Unit (AU)/mL | Human T-Cadherin(130K) |
| Assay Time | Overnight + 1 hr 30 mins (incubation) | Overnight + 1 hr 30 mins (incubation) | 2 hrs, 30 mins (incubation) | 36 to 48 hrs (total) | 1 hr 15 mins (incubation) |